General
Memphis Pharmaceuticals (MPCI.CA) - Central Auditing Organization's Report
Published at 2 June 2026 at 11:38Memphis PharmaceuticalsRelated stock:Memphis Pharmaceuticals stockAll Memphis Pharmaceuticals disclosures
Disclosure summary
Company Name : Memphis Pharmaceuticals
ISIN Code : EGS38351C010
Reuters Code : MPCI.CA
Content :
The Central Auditing Organization's report on the financial statements for the financial period ending 31/03/2026.
The Central Auditing Organization's Report (1,013 KB)
ISIN Code : EGS38351C010
Reuters Code : MPCI.CA
Content :
The Central Auditing Organization's report on the financial statements for the financial period ending 31/03/2026.
The Central Auditing Organization's Report (1,013 KB)